Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure

T A Slotkin1, M M Cousins, C A Tate

  • 1Department of Pharmacology and Cancer Biology, Box 3813 DUMC, Duke University Medical Center, 27710, Durham, NC, USA. t.slotkin@duke.edu

Brain Research
|June 1, 2001
PubMed

Insights

Neonatal exposure to chlorpyrifos (CPF) insecticide causes lasting damage to brain cell development and function. These effects are widespread, gender-specific, and persist into adulthood, impacting behavior.

Area of Science:

  • Neuroscience
  • Toxicology
  • Developmental Biology

Background:

  • Organophosphate insecticides like chlorpyrifos (CPF) are widely used.
  • CPF is known to impair crucial brain development processes, including axonogenesis and synaptogenesis.

Purpose of the Study:

  • To investigate the long-term effects of neonatal chlorpyrifos exposure on cholinergic synaptic markers.
  • To determine the impact of CPF on brain development, considering different exposure timings, brain regions, and gender.

Main Methods:

  • Neonatal rats were exposed to CPF at two different early life stages (PN1-4 or PN11-14).
  • Choline acetyltransferase activity (ChAT) and [3H]hemicholinium-3 binding (HC-3) were measured in various brain regions at juvenile (PN30) and young adult (PN60) stages.
  • Effects were analyzed across different brain regions, genders, and exposure timings.

Main Results:

  • CPF exposure led to significant reductions in both ChAT and HC-3 markers across all examined brain regions.
  • HC-3 binding showed greater sensitivity to CPF than ChAT, indicating impacts on neuronal impulse activity.
  • Distinct gender-selective effects and regional vulnerabilities were observed, with some effects persisting into adulthood.
  • Early exposure (PN1-4) had more pronounced effects on HC-3 in the hippocampus, while later exposure (PN11-14) showed gender-specific impacts in the midbrain and striatum.

Conclusions:

  • Neonatal chlorpyrifos exposure induces widespread and persistent deficits in cholinergic synaptic function.
  • These neurodevelopmental effects are region-specific and gender-selective, with critical windows of vulnerability.
  • The observed synaptic dysfunction likely contributes to long-lasting behavioral alterations, even after cholinesterase activity is restored.

Related Concept Videos

Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...